University Of Louisville
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1798-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.louisville.edu
Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
- Conditions
- Anemia
- Interventions
- Drug: Epoetin Alfa plus Iron
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2018-03-05
- Lead Sponsor
- University of Louisville
- Registration Number
- NCT00481624
- Locations
- 🇺🇸
James Graham Brown Cancer Center, Louisville, Kentucky, United States
A Phase I Study of Intraperitoneal Hyperthermic Docetaxel
- First Posted Date
- 2007-05-17
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 30
- Registration Number
- NCT00474669
- Locations
- 🇺🇸
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO)
- Conditions
- Coronary Artery DiseaseCongestive Heart Failure
- Interventions
- Biological: Treatment group
- First Posted Date
- 2007-05-17
- Last Posted Date
- 2017-04-11
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 33
- Registration Number
- NCT00474461
- Locations
- 🇺🇸
Jewish Hospital, Louisville, Kentucky, United States
rhGH Therapy on Hepatic Drug Metabolism
- Conditions
- Growth Hormone Deficiency, Dwarfism
- First Posted Date
- 2007-04-11
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 9
- Registration Number
- NCT00458991
- Locations
- 🇺🇸
University of California at San Diego, San Diego, California, United States
🇺🇸Children's Mercy Hospital and Clinics, Kansas City, Missouri, United States
🇺🇸Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2019-10-30
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 39
- Registration Number
- NCT00456989
- Locations
- 🇺🇸
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Risk Factors for Progressive Supranuclear Palsy (PSP)
- Conditions
- Progressive Supranuclear Palsy
- First Posted Date
- 2007-02-05
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 942
- Registration Number
- NCT00431301
- Locations
- 🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸Emory College of Medicine, Atlanta, Georgia, United States
🇺🇸Rush University, Chicago, Illinois, United States
Racial Disparity in Endometrial Cancer
- Conditions
- Endometrial Cancer
- First Posted Date
- 2006-09-13
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 43
- Registration Number
- NCT00375804
- Locations
- 🇺🇸
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
- Conditions
- Leukemia, Lymphocytic, ChronicLymphoma, Small Lymphocytic
- First Posted Date
- 2006-02-13
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 2
- Registration Number
- NCT00290407
- Locations
- 🇺🇸
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Prognostic Markers of Gynecologic Cancers
- Conditions
- Gynecologic CancerGynecologic Disease
- First Posted Date
- 2006-02-13
- Last Posted Date
- 2021-03-30
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 1321
- Registration Number
- NCT00290459
- Locations
- 🇺🇸
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer
- First Posted Date
- 2006-01-24
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 26
- Registration Number
- NCT00281021